Bronchoalveolar lavage fluid cytokine-based clustering identifies prognostically relevant cytokine phenotypes across interstitial lung diseases

BACKGROUND: Existing classification systems for interstitial lung diseases (ILDs) are limited and do not fully reflect the underlying biological drivers. We sought to identify cytokine-defined ILD subgroups based on bronchoalveolar lavage fluid (BALF) cytokine profiles and to examine their clinical relevance, particularly their association with prognosis. METHODS: We reanalyzed a BALF cytokine dataset from 84 patients with ILDs, including idiopathic pulmonary fibrosis (IPF), idiopathic nonspecific interstitial pneumonia (iNSIP), cryptogenic organizing pneumonia, sarcoidosis, idiopathic inflammatory myopathy-associated ILD, and RA-ILD. Cytokine concentrations were measured using a multiplex bead-based assay. We used hierarchical clustering, principal component, correspondence, cosine similarity, and discriminant analyses to identify cytokine-defined subgroups and examine their clinical associations. RESULTS: We identified three cytokine-level-defined clusters: Clusters 1, 2, and 3, characterized by globally high, intermediate, and low cytokine levels, respectively. Clusters 1 and 3 were associated with poor and favorable prognoses, respectively. Cytokine-defined clusters did not fully correspond with conventional disease categories, although Cluster 3 predominantly included patients with sarcoidosis. RA-ILD was mainly distributed in Clusters 1 and 2 together with IPF, iNSIP, COP, and IIM-ILD. However, RA-ILD was distinguished by relatively elevated interleukin-17 and granulocyte-macrophage colony-stimulating factor levels. CONCLUSIONS: BALF cytokine profiling can identify cytokine intensity-defined ILD subgroups that are associated with prognosis and are not fully captured by conventional disease classification. Although RA-ILD shares cytokine features with IPF and iNSIP, it also exhibits distinct immune characteristics. These findings suggest that intrapulmonary cytokine profiling could facilitate ILD stratification.

Authors

Institutions

Publication Details

Journal
Respiratory Investigation
Published
2026-09-18
DOI
https://doi.org/10.1016/j.resinv.2026.101511
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Bronchoalveolar lavage fluid cytokine-based clustering identifies prognostically relevant cytokine phenotypes across interstitial lung diseases

Wataru Fujii, Tomoyuki Miyao, Kazuhiro Kurasawa, Takayoshi Owada et al.
Respiratory Investigation
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Bronchoalveolar lavage fluid cytokine-based clustering identifies prognostically relevant cytokine phenotypes across interstitial lung diseases

Wataru Fujii, Tomoyuki Miyao, Kazuhiro Kurasawa, Takayoshi Owada, Masafumi Arima, Satoko Arai, Reika Maezawa, Kei Ikeda, Ayae Tanaka
article en

Abstract

BACKGROUND: Existing classification systems for interstitial lung diseases (ILDs) are limited and do not fully reflect the underlying biological drivers. We sought to identify cytokine-defined ILD subgroups based on bronchoalveolar lavage fluid (BALF) cytokine profiles and to examine their clinical relevance, particularly their association with prognosis. METHODS: We reanalyzed a BALF cytokine dataset from 84 patients with ILDs, including idiopathic pulmonary fibrosis (IPF), idiopathic nonspecific interstitial pneumonia (iNSIP), cryptogenic organizing pneumonia, sarcoidosis, idiopathic inflammatory myopathy-associated ILD, and RA-ILD. Cytokine concentrations were measured using a multiplex bead-based assay. We used hierarchical clustering, principal component, correspondence, cosine similarity, and discriminant analyses to identify cytokine-defined subgroups and examine their clinical associations. RESULTS: We identified three cytokine-level-defined clusters: Clusters 1, 2, and 3, characterized by globally high, intermediate, and low cytokine levels, respectively. Clusters 1 and 3 were associated with poor and favorable prognoses, respectively. Cytokine-defined clusters did not fully correspond with conventional disease categories, although Cluster 3 predominantly included patients with sarcoidosis. RA-ILD was mainly distributed in Clusters 1 and 2 together with IPF, iNSIP, COP, and IIM-ILD. However, RA-ILD was distinguished by relatively elevated interleukin-17 and granulocyte-macrophage colony-stimulating factor levels. CONCLUSIONS: BALF cytokine profiling can identify cytokine intensity-defined ILD subgroups that are associated with prognosis and are not fully captured by conventional disease classification. Although RA-ILD shares cytokine features with IPF and iNSIP, it also exhibits distinct immune characteristics. These findings suggest that intrapulmonary cytokine profiling could facilitate ILD stratification.

Respiratory InvestigationVol. 64(6)
Dokkyo Medical University Saitama Medical Center (JP), Dokkyo Medical University (JP)
AbbVie
Openalex Percentile: Top 11%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.